Clinical Trial Update: Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial for NM8074 in antineutrophil cytoplasmic antibody-associated vasculitis is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antineutrophil Cytoplasmic Antibody-associated Vasculitis

Drugs mentioned

• NM8074

Snippet

Sponsor: NovelMed Therapeutics | Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Phase 2 | Status: NOT_YET_RECRUITING